Diffusion Pharmaceuticals...

NASDAQ: DFFN · Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM

Diffusion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9M 10.11M 37.31M
Short-Term Investments
29.92M 12.41M n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
n/a n/a 15.58K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
4.16M 112.41K 510.01K
Total Current Assets
43.08M 22.64M 37.82M
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
n/a n/a 15.58K
Total Assets
43.08M 22.64M 37.84M
Account Payables
1.51M 1.13M 947.5K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
n/a n/a 1.98M
Total Current Liabilities
1.51M 2.42M 2.93M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
2.37M n/a n/a
Total Long-Term Liabilities
2.37M 1.29M n/a
Total Liabilities
3.88M 2.42M 2.93M
Total Debt
n/a n/a n/a
Common Stock
8.7K 2.04K 101.91K
Retained Earnings
-70.73M -145.6M -130.01M
Comprehensive Income
56.2K -35.38K n/a
Shareholders Equity
39.2M 20.22M 34.91M
Total Investments
n/a 12.41M n/a